Michigan Biosciences Industry Association Logo

Federal Advocacy

Stay updated on federal initiatives and policies influencing the bio-industry across the country. This category highlights national-level advocacy efforts, initiatives, and developments driving innovation and growth across the industry.

Advocacy Advocacy : Federal Advocacy Advocacy : State Advocacy Association Updates Event Event : Industry Event Event : MichBio Advocacy Events Event : MichBio Networking Event Event : MichBio Signature Event Event : MichBio Webinar Event : Partner Event Member Feature News News : Industry News News : Member News News : MichBio News/Statement News : Michigan News
Epic Act Reintroduced
Posted In: Federal Advocacy,
Date posted Mar 4

Discover MichBio, Michigan's bioscience industry leader. Explore membership benefits, events, advocacy efforts, and the latest news on drug...

Read Post
Getting Involved: Contacting Your Michigan Congressional Office
Posted In: Federal Advocacy,
Date posted Feb 11

Advocate for bioscience funding in Michigan! Learn how to contact your Congressional representatives and support vital biomedical research...

Read Post
Federal Advocacy Outlook 2025: Early 2025
Posted In: Federal Advocacy,
Date posted Jan 22

Explore MichBio's insights on federal advocacy for 2025, focusing on policy impacts, tax reforms, and industry growth strategies in the biosciences...

Read Post
Attempts to Regulate Drug Pricing Fail During Legislative Chaos
Posted In: Federal Advocacy,
Date posted Dec 31

Discover the latest on drug pricing reforms in Michigan, including legislative challenges and opposition from key industry groups like MichBio and...

Read Post
Biosecure Act Fails to be Enacted
Posted In: Federal Advocacy,
Date posted Dec 31

Stay updated on the BIOSECURE Act's challenges in Congress and its implications for U.S. biotech. Learn more about MichBio's advocacy efforts.

Read Post
CMS Finalizes Accelerated Approval Pathway for Devices
Posted In: Federal Advocacy,
Date posted Dec 31

Explore MichBio's resources for the bio-industry, including membership benefits, events, advocacy, and the latest news on medical technology...

Read Post
Ensuring Patient Access to Critical Breakthrough Products
Posted In: Federal Advocacy,
Date posted Dec 31

Stay informed on the "Ensuring Patient Access to Critical Breakthrough Products Act," aimed at expediting Medicare coverage for innovative medical...

Read Post
Section 174 Struggles Persist: Advocacy Pushes for Relief
Posted In: Federal Advocacy,
Date posted Dec 31

Stay updated on MichBio's advocacy efforts for R&D tax relief and the impact of Section 174 on life science companies. Join us in pushing for change!

Read Post
House Approves BIOSECURE Act
Posted In: Federal Advocacy,
Date posted Oct 22

Stay updated on the BIOSECURE Act's passage and its implications for biotechnology contracts. Learn about its provisions and potential impacts on...

Read Post
CMS Finalizes Expedited TCET Coverage Pathway
Posted In: Federal Advocacy,
Date posted Aug 28

Discover MichBio's latest news on the new TCET coverage pathway, expediting Medicare for FDA-approved devices. Stay informed on bioscience...

Read Post
First Drugs Subject to Inflation Reduction Act Price Provisions
Posted In: Federal Advocacy,
Date posted Aug 28

Stay informed on MichBio's advocacy for drug price negotiations under the Inflation Reduction Act, impacting Medicare and innovation in the biotech...

Read Post
FTC Meeting Highlights Urgent Need for PBM Reforms To Protect Patients
Posted In: Federal Advocacy,
Date posted Aug 28

Join MichBio in advocating for Pharmacy Benefit Manager reforms to enhance patient access to affordable medications. Stay informed on bioscience...

Read Post